Meet Our CEO

Dr. Jeff Schwegman

Thank you for considering AB BioTechnologies, Inc. for your parenteral and diagnostic development needs. We are an experienced company with formulation, analytical, and lyophilization development services for both small and large molecules, and we have been providing these services with quality in a timely, cost effective manner since 2008. Being a small, privately held corporation means that we can work quickly, efficiently, and for a very competitive price, while still offering the personal service that companies desire for their outsourced development needs. We are currently in the process of expanding our service line to include manufacturing of the parenteral products we develop. The new manufacturing line in our new facility will allow us to manufacture cGMP supplies for Toxicological, Pre-Clinical, and Phase I Clinical Trials. This will offer a seamless transition for our clients as we move from the early development phase of a drug product to the early phase manufacturing. There is a very short window of exclusivity for new drugs after discovery, and therefore, it is imperative that the formulation development, process development, and Clinical supplies manufacturing be conducted correctly the first time, in an efficient, time conscience manner, while still meeting all of the required quality and safety standards for these products. Being a small, privately held, experienced company, AB BioTechnologies can operate efficiently, and within a tight budget, and it is our mission to meet these strict client demands for development services and safe, high quality drug products for early phase Clinical Trials.